OnControl Powered Bone Access Systems;OnControl Bone Marrow Aspiration System;OnControl Bone Marrow Biopsy System;OnControl Bone Lesion Biopsy System;OnControl Power Driver
Teleflex Medical LLC · Decision date Oct 27, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on October 27, 2026 for Teleflex Medical, LLC's OnControl Powered Bone Access Systems, covering the Bone Marrow Aspiration System, Bone Marrow Biopsy System, Bone Lesion Biopsy System and Power Driver. The submission K262531 was received July 22, 2026 under 21 CFR 876.1075 (biopsy instrument, Class II, product code KNW). SESE is a 510(k) clearance, not a PMA approval.
The 510(k) summary lists K142377 as predicate and K070759 and K113872 as reference devices, and describes changes including added needle-set components and sizes, packaging modifications, printed circuit board and firmware changes, and updated performance specifications. Bench and biocompatibility testing is cited as support. The summary does not report clinical outcome data, and no post-market commitments or limitations are stated in the provided documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Oct 27, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262531
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Teleflex Medical LLC
- Product code
- KNW
- Decision code
- SESE
- Decision date
- Oct 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Instrument, Biopsy.
- Applicant
- Teleflex Medical LLC
- Product code
- KNW
- FDA device class
- 2
FDA decision timeline
K262531 received
Application receipt date recorded by FDA.
K262531 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Teleflex Medical LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Morrisville, NC
Sources and methodology
- Original FDA record: K262531
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records